Free Trial

Brevan Howard Capital Management LP Increases Stake in Molina Healthcare, Inc. (NYSE:MOH)

Molina Healthcare logo with Medical background

Brevan Howard Capital Management LP increased its holdings in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 96.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,313 shares of the company's stock after acquiring an additional 6,039 shares during the quarter. Brevan Howard Capital Management LP's holdings in Molina Healthcare were worth $3,584,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently made changes to their positions in the business. Tributary Capital Management LLC raised its position in Molina Healthcare by 76.1% in the 4th quarter. Tributary Capital Management LLC now owns 4,190 shares of the company's stock worth $1,219,000 after buying an additional 1,811 shares during the last quarter. Smartleaf Asset Management LLC lifted its position in Molina Healthcare by 123.9% during the fourth quarter. Smartleaf Asset Management LLC now owns 347 shares of the company's stock valued at $100,000 after purchasing an additional 192 shares during the period. SYM FINANCIAL Corp purchased a new stake in Molina Healthcare in the fourth quarter worth approximately $249,000. Summit Trail Advisors LLC bought a new stake in Molina Healthcare in the 4th quarter worth approximately $452,000. Finally, Entropy Technologies LP raised its stake in Molina Healthcare by 58.1% during the 4th quarter. Entropy Technologies LP now owns 4,594 shares of the company's stock valued at $1,337,000 after buying an additional 1,688 shares during the last quarter. 98.50% of the stock is currently owned by hedge funds and other institutional investors.

Molina Healthcare Price Performance

Shares of NYSE MOH traded down $0.65 during midday trading on Thursday, reaching $326.37. 553,777 shares of the stock traded hands, compared to its average volume of 679,677. The company's 50 day moving average is $324.37 and its 200 day moving average is $307.98. Molina Healthcare, Inc. has a one year low of $262.32 and a one year high of $365.23. The stock has a market capitalization of $17.69 billion, a PE ratio of 15.97, a P/E/G ratio of 1.06 and a beta of 0.63. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.62 and a quick ratio of 1.62.

Molina Healthcare (NYSE:MOH - Get Free Report) last released its quarterly earnings results on Wednesday, April 23rd. The company reported $6.08 earnings per share for the quarter, beating the consensus estimate of $5.96 by $0.12. The company had revenue of $11.15 billion for the quarter, compared to analyst estimates of $10.86 billion. Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. Molina Healthcare's quarterly revenue was up 12.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $5.73 EPS. On average, equities research analysts anticipate that Molina Healthcare, Inc. will post 24.4 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the stock. Baird R W cut shares of Molina Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Stephens reissued an "equal weight" rating and set a $345.00 price objective on shares of Molina Healthcare in a research report on Thursday, February 6th. Mizuho raised their target price on Molina Healthcare from $376.00 to $400.00 and gave the stock an "outperform" rating in a report on Wednesday, April 9th. UBS Group reduced their price target on Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating for the company in a research report on Friday, February 7th. Finally, Robert W. Baird reaffirmed a "neutral" rating and set a $375.00 price objective (up from $331.00) on shares of Molina Healthcare in a research report on Tuesday, April 15th. Nine research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat, Molina Healthcare has a consensus rating of "Hold" and a consensus target price of $365.38.

Get Our Latest Research Report on MOH

Insiders Place Their Bets

In related news, Director Steven J. Orlando sold 1,000 shares of the firm's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $301.33, for a total value of $301,330.00. Following the transaction, the director now owns 17,375 shares of the company's stock, valued at $5,235,608.75. This trade represents a 5.44 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Richard M. Schapiro sold 669 shares of the business's stock in a transaction dated Tuesday, April 29th. The shares were sold at an average price of $320.50, for a total transaction of $214,414.50. Following the completion of the sale, the director now directly owns 11,244 shares of the company's stock, valued at approximately $3,603,702. This trade represents a 5.62 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 89,169 shares of company stock valued at $28,520,995 over the last 90 days. Insiders own 1.10% of the company's stock.

Molina Healthcare Company Profile

(Free Report)

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

Further Reading

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

Should You Invest $1,000 in Molina Healthcare Right Now?

Before you consider Molina Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.

While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025
3 Sectors With Massive Momentum You Can’t Afford to Miss
Palantir’s Big Moves: Profit-Taking, Price Targets & AI Potential

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines